From Casetext: Smarter Legal Research

Chartwell Therapeutics Licensing LLC v. Alvogen, Inc.

United States District Court, Southern District of New York
Jul 19, 2021
20 CV 6209 (VB) (S.D.N.Y. Jul. 19, 2021)

Opinion

20 CV 6209 (VB)

07-19-2021

CHARTWELL THERAPEUTICS LICENSING LLC, Plaintiff, v. ALVOGEN, INC., Defendant.


ORDER

Vincent L. Briccetti United States District Judge

Defendant having filed a partial motion to dismiss the amended complaint pursuant to Rule 12(b)(6) (Doc. #46), it is HEREBY ORDERED:

1. Defendant's motion is DENIED.

2. By August 2, 2021, defendant shall file an answer.

3. A telephone conference is scheduled for August 26, 2021, at 2:30 p.m., at which time the Court will issue a bench ruling explaining the basis for its decision. This conference shall also serve as an initial conference in this matter. All counsel shall use the following information to connect by telephone:

Dial-In Number: (888) 363-4749 (toll free) or (215) 446-3662
Access Code: 1703567

4. By August 23, 2021, counsel shall file on the ECF docket their proposed Civil Case Discovery Plan and Scheduling Order, a blank copy of which will be attached to the Notice of Initial Conference. The Notice will be separately docketed.

5. The Clerk is instructed to terminate the motion. (Doc. #46).

SO ORDERED:


Summaries of

Chartwell Therapeutics Licensing LLC v. Alvogen, Inc.

United States District Court, Southern District of New York
Jul 19, 2021
20 CV 6209 (VB) (S.D.N.Y. Jul. 19, 2021)
Case details for

Chartwell Therapeutics Licensing LLC v. Alvogen, Inc.

Case Details

Full title:CHARTWELL THERAPEUTICS LICENSING LLC, Plaintiff, v. ALVOGEN, INC.…

Court:United States District Court, Southern District of New York

Date published: Jul 19, 2021

Citations

20 CV 6209 (VB) (S.D.N.Y. Jul. 19, 2021)